Goutham Talluri
Nephrology · Alexandria, LANPI 1588226229
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Fresenius USA Marketing, Inc. at 25.0% of the total. That places this record below the midpoint for nephrology clinicians in LA, where the typical reported total is $1,900.
Across 46 payments — averaging $21.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius USA Marketing, Inc.$252
- Novartis$164
- Otsuka America Pharmaceutical, Inc.$151
- Calliditas Therapeutics US Inc.$144
- Bayer$97
- AstraZeneca$35
- plus $162 from 7 others
What the payments were for
- Food & beverage$1,004100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius USA Marketing, Inc. | 14 | $252 |
| Novartis | 7 | $164 |
| Otsuka America Pharmaceutical, Inc. | 5 | $151 |
| Calliditas Therapeutics US Inc. | 5 | $144 |
| Bayer | 5 | $97 |
| AstraZeneca | 2 | $35 |
| Novo Nordisk | 1 | $28 |
| Travere Therapeutics, Inc. | 2 | $26 |
| Cormedix Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
| Amgen | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $17 |
How this compares
$1,005 in reported general payments places this provider in the 30th percentile of 206 nephrology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Alexandria
- Rajat GulatiAlexandria$5K
- Sreedhara AllaShreveport$722K
- Anthony BlalockLafayette$350K
- Juan Carlos VelezNew Orleans$282K
- Jones SamuelBaton Rouge$207K
- Jon MaresCovington$103K
- Raja ZabanehShreveport$57K
- Michael TouchyNew Orleans$56K
- Kenneth AbreoShreveport$42K
- Michael LiuOpelousas$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.